Pannus invasion and cartilage degradation in rheumatoid arthritis: Involvement of MMP-3 and interleukin-1β

Clinical and Experimental Rheumatology

Volumn 23, Issue 5, 2005, Pages 644-650

  Ainola, Mari M ^a   Mandelin, Jami A ^a   Liljeström, Mikko P ^a   Li, Tian Fang ^a   Hukkanen, Mika V J ^a   Konttinen, Yrjö T ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cartilage; Cytokines; Inflammation; Matrix metalloproteinases; Rheumatoid arthritis

Indexed keywords

COLLAGENASE 3; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PROTEOGLYCAN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FROZEN SECTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PANNUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CARTILAGE DISEASES; COLLAGENASES; HUMANS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL MEMBRANE; SYNOVITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24944502379     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. PELTONEN L, PALOTIE A, LANGE K: Use of population isolates for mapping complex traits. Nat Rev Genet 2000; 1: 182-90.
2. KONTTINEN YT, SAARI H, SANTAVIRTA S et al.: Synovial fibroblasts. Scand J Rheumatol 1988; 76 (Suppl.): 95-103.
3. KONTTINEN YT, LI TF, HUKKANEN M, MA J, XU JW, VIRTANEN I: Fibroblast biology. Signals targeting the synovial fibroblast in arthritis. Arthritis Res 2000; 2: 348-55.
4. KONTTINEN YT, REITAMO S, RANKI A, HAYRY P, KANKAANAPAA U, WEGELIUS O: Characterization of the immunocompetent cells of rheumatoid synovium from tissue sections and eluates. Arthritis Rheum 1981; 24: 71-9.
5. SHIOZAWA S, SHIOZAWA K, FUJITA T: Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus. Arthritis Rheum 1983; 26: 472-8.
6. SHIOZAWA S, ZIFF M: Immunoelectron microscopic demonstration of fibronectin in rheumatoid pannus and at the cartilage-pannus junction. Ann Rheum Dis 1983; 42:254-63.
7. KONTTINEN YT, CEPONIS A, TAKAGI M et al.: New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol 1998; 17: 585-601.
8. KONTTINEN YT, SALO T, HANEMAAIJER R et al.: Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol 1999; 18: 401-12.
9. GRAVALLESE EM, MANNING C, TSAY A et al.: Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000; 43: 250-8.
10. TAKAYANAGI H, IIZUKA H, JUJI T et al.: Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000; 43: 259-69.
11. STAMENKOVIC I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000; 10: 415-33.
12. TOLBOOM TC, PIETERMAN E, van der LAAN WH et al.: Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 2002; 61: 975-80.
13. KONTTINEN YT, AINOLA M, VALLEALA H et al.: Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999; 58: 691-7.
14. HASTY KA, REIFE RA, KANG AH, STUART JM: The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum 1990; 33: 388-97.
15. SORSA T, KONTTINEN YT, LINDY O et al.: Collagenase in synovitis of rheumatoid arthritis. Semin Arthritis Rheum 1992; 22: 44-53.
16. YOSHIHARA Y, NAKAMURA H, OBATA K et al.: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000; 59: 455-61.
17. ISHIGURO N, ITO T, OGUCHI T et al.: Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum 2001; 44: 2503-11.
18. TETLOW LC, WOOLLEY DE: Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995; 54: 896-903.
19. FELDMANN M, BRENNAN FM, MAINI RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
20. MARINOVA-MUTAFCHIEVA L, WILLIAMS RO, MASON LJ, MAURI C, FELDMANN M, MAINI RN: Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin Exp Immunol 1997; 107: 507-12.
21. SAUS J, QUINONES S, OTANI Y, NAGASE H, HARRIS ED Jr, KURKINEN M: The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin. J Biol Chem 1988; 263: 6742-5.
22. MacNAUL KL, CHARTRAIN N, LARK M, TOCCI MJ, HUTCHINSON NI: Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 1990; 265: 17238-45.
23. FIRESTEIN GS, PAINE MM: Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. Am J Pathol 1992; 140: 1309-14.
24. BORGHAEI RC, SULLIVAN C, MOCHAN E: Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3). J Biol Chem 1999; 274: 2126-31.
25. van den BERG WB: The role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis. Z Rheumatol 1999; 58: 136-41.
26. KONTTINEN YT, NYKANEN P, NORDSTROM D et al.: DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study. J Rheumatol 1989; 16: 339-45.
27. YOSHIHARA Y, OBATA K, FUJIMOTO N, YAMASHITA K, HAYAKAWA T, SHIMMEI M: Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 969-75.
28. ISHIGURO N, ITO T, OBATA K, FUJIMOTO N, IWATA H: Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J Rheumatol 1996; 23: 1599-604.
29. KANE D, JENSEN LE, GREHAN S, WHITEHEAD AS, BRESNIHAN B, FITZGERALD O: Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction. J Rheumatol 2004 Jul; 31: 1274-1280.
30. POSTHUMUS MD, LIMBURG PC, WESTRA J et al.: Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 1081-7.
31. CHEUNG NT, DAWES PT, POULTON KV, OLLIER WE, TAYLOR DJ, MATTEY DL: High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis. J Rheumatol 2000; 27: 882-7.
32. YAMANAKA H, MATSUDA Y, TANAKA M et al.: Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000; 43: 852-8.
33. GREEN MJ, GOUGH AK, DEVLIN J et al.: Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2003; 42: 83-8.
34. POSTHUMUS MD, LIMBURG PC, WESTRA J, van LEEUWEN MA, van RIJSWIJK MH: Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression. J Rheumatol 2000; 27: 2761-8.
35. POSTHUMUS MD, LIMBURG PC, WESTRA J, van LEEUWEN MA, van RIJSWIJK M: Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis. Clin Exp Rheumatol 2003; 21: 465-72.
36. MAEDA S, SAWAI T, UZUKI M et al.: Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 970-5.
37. KOZACI LD, BUTTLE DJ, HOLLANDER AP: Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum 1997; 40: 164-74.
38. SAITO S, KATOH M, MASUMOTO M, MATSUMOTO S, MASUHO Y: Involvement of MMP-1 and MMP-3 in collagen degradation induced by IL-1 in rabbit cartilage explant culture. Life Sci 1998; 62: 359-65.
39. FRASER A, FEARON U, BILLINGHURST RC et al.: Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: Relationship to mediators of systemic and local inflammation. Arthritis Rheum 2003; 48: 3085-95.
40. van MEURS JB, van LENT PL, van de LOO AA et al.: Increased vulnerability of postarthritic cartilage to a second arthritic insult: accelerated MMP activity in a flare up of arthritis. Ann Rheum Dis 1999; 58: 350-6.
41. TETLOW LC, WOOLLEY DE: Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. Br J Rheumatol 1998; 37: 64-70.
42. HE CS, WILHELM SM, PENTLAND AP et al.: Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 1989; 86: 2632-6.
43. ABRAMSON SB, AMIN A: Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford) 2002; 41: 972-80.
44. SMEETS RL, van de LOO FA, JOOSTEN LA et al.: Effectiveness of the soluble form of the interteukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis. Arthritis Rheum 2003; 48: 2949-58.
45. van de LOO AA, Van den BERG WB: Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 1990; 49: 238-45.
46. GHIVIZZANI SC, KANG R, GEORGESCU HI et al.: Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol 1997; 159: 3604-12.
47. van den BERG WB: Joint inflammation and cartilage destruction may occur uncoupled. Springer Semin Immunopathol 1998; 20: 149-64.
48. van den BERG WB, JOOSTEN LA, van de LOO FA: TNF alpha and IL-1 beta are separate targets in chronic arthritis. Clin Exp Rheumatol 1999; 17: 105-14.
49. KONTTINEN YT, BERGROTH V, NORDSTROM D et al.: Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis. Ann Rheum Dis 1985; 44: 549-55.